Video Journal of Hematology & Hematological Oncology (VJHemOnc)’s Post

Learn more about the MoU signed by the Department of Health - Abu Dhabi and MSD at the BIO International Convention 2024 and how it advances clinical research on lung cancer. MSD Ashraf Mallak Shahrukh Hashmi #AHealthierAbuDhabi #Healthcare #BIO2024

NEW from #ASCO24 | The potential of #ctDNA in monitoring disease progression in #metastatic #colorectalcancer 🎥 Kanwal Pratap Singh Raghav, MBBS, MD, The University of Texas MD Anderson Cancer Center, discusses the potential of #circulatingtumor (#ctDNA) in monitoring disease progression in #metastaticcolorectalcancer (#mCRC) While acknowledging the promise of #ctDNA, Dr Raghav highlights challenges such as the lack of standardized assays and the need for more randomized #trials to establish appropriate cutoffs and testing intervals. Despite these hurdles, he expresses optimism about the future integration of #ctDNA monitoring into regular #clinicalpractice, emphasizing its potential to enhance precision care in mCRC 🔦 Learn more 👉 https://lnkd.in/eySH6FXm #VJOncology #Oncologynews

#𝐖𝐡𝐚𝐭𝐬𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠: 𝐍𝐚𝐧𝐨𝐫𝐨𝐛𝐨𝐭𝐬 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐞𝐝 𝐭𝐨 𝐊𝐢𝐥𝐥 𝐂𝐚𝐧𝐜𝐞𝐫 𝐂𝐞𝐥𝐥𝐬 𝐢𝐧 𝐌𝐢𝐜𝐞 𝐒𝐭𝐚𝐲 𝐈𝐧𝐟𝐨𝐫𝐦𝐞𝐝! 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐚𝐭 𝐊𝐚𝐫𝐨𝐥𝐢𝐧𝐬𝐤𝐚 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐭 𝐢𝐧 𝐒𝐰𝐞𝐝𝐞𝐧 have made an extraordinary breakthrough by developing Nanorobots that target and destroy cancer cells in mice. These innovative nanorobots remain dormant until activated by the acidic microenvironment typically found in solid tumors, ensuring the protection of healthy cells. Upon activation, cell-killing peptides are released, leading to a remarkable 𝟕𝟎% 𝐫𝐞𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐮𝐦𝐨𝐫 𝐠𝐫𝐨𝐰𝐭𝐡 in mice with breast cancer compared to those given an inactive version of the nanorobot. This groundbreaking advancement represents a significant leap forward in cancer treatment, promising more targeted and effective therapies in the future. At 𝐒𝐡𝐚𝐫𝐝𝐚 𝐂𝐚𝐫𝐞 - 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐢𝐭𝐲, your well-being is our top priority. Keep a watchful eye by 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐨𝐮𝐫 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 for important updates, expert guidance, and necessary precautions. Together, we stay informed and resilient. ✨ Follow us for more updates! 𝐒𝐨𝐮𝐫𝐜𝐞: 𝐊𝐚𝐫𝐨𝐥𝐢𝐧𝐬𝐤𝐚 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐭 #CancerResearch #Nanotechnology #MedicalInnovation #KarolinskaInstitutet #CancerTreatment #Nanorobots #HealthcareAdvances #FutureOfMedicine #BreastCancer Sunel Satya Kapur bhagya lakshmi JAGDAMBA PRASAD Rohit Bhatia Abhishek Dubey Nirmal Gera

What if there could be a new way to fight breast cancer? Irida's research is exploring whether holding back a key protein could transform cancer treatment. Learn more at ChicagoITM.org > News https://lnkd.in/gw72av97 - “Our science has shown that tumors rely on a certain protein to thrive, and now we have found a better way to hold this protein back.” - ITM Pilot Award winner, Irida Kastrati #ITM #ChicagoITM #healthresearch #CTSAProgram #NIH #CCOSCTSA #NCATS #ITMPilotAward #SciComms #SciComm #ScienceCommunications #ScienceCommunication #ChicagoITMFunding #ITMFunding #LoyolaChicago #LoyolaUniversityChicago #ITMLoyola #LoyolaParkinson The National Institutes of Health CTSA CCOS Center National Center for Advancing Translational Sciences (NCATS) Loyola University Chicago Loyola University Chicago Stritch School of Medicine Parkinson School of Health Sciences and Public Health, Loyola University Chicago Irida Kastrati

The study analyzed the safety and effectiveness of a modified protocol combining pembrolizumab with dose-dense doxorubicin and cyclophosphamide in treating early-stage triple-negative breast cancer. Results showed a higher pathologic complete response rate with the modified protocol, and no serious adverse events related to pembrolizumab were reported. The findings suggest that this approach could be a promising treatment option for this patient population, although larger studies are needed for further evaluation. #BreastCancer #Immunotherapy #Biohacking #HealthResearch #TreatmentOptimization Read more here: https://lnkd.in/e58Tn-aD BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X.

🔬 On 𝐖𝐨𝐫𝐥𝐝 𝐂𝐚𝐧𝐜𝐞𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐃𝐚𝐲, we highlight the critical importance of research in transforming the future of cancer care. ⚗The 𝐄𝐋𝐌𝐔𝐌𝐘 project is focused on tackling #multiplemyeloma, a rare but aggressive blood cancer. With groundbreaking #research, we aim to develop more targeted treatments and improve the quality of life for patients affected by this disease. 🌍 By fostering #collaboration across Europe’s top research institutions and medical experts, we’re accelerating progress toward innovative solutions. Every discovery brings us one step closer to better treatment outcomes. 💡 Research is key to making this vision a reality. #MissionCancer #HorizonEU #WorldCancerResearchDay #MultipleMyeloma #EUfunded #CancerResearch 

Breakthrough News in Blood Cancer Treatment: Czech Scientists Pioneer Cost-Effective Therapy 🔬 Czech scientists in Ostrava have achieved a remarkable breakthrough in blood cancer treatment, potentially revolutionizing how we combat this disease. 🩸 Multiple Myeloma Targeted: The research team, led by Michal Šimíček, focused on multiple myeloma—a cancer that affects hundreds of people annually in the Czech Republic. Their innovative method, successfully tested on mice, offers hope for more effective treatments. 💡 Cost-Effective Solution: The technology developed by the Blood Cancer Research Group, founded by Professor Roman Hájek, could significantly reduce treatment costs—up to tenfold! This affordability leap is crucial for patients and healthcare systems alike. 🌐 Personalized Medicine: Michal Zahradníček, a key contributor, highlights the transformative impact of the new therapy. His venture, LIFE BioCEEd, underscores Czechia’s commitment to cutting-edge biomedical technologies. Imagine treatments tailored precisely to individual patients’ needs! Source: https://lnkd.in/d4wbkKqX 👈 #BloodCancerResearch #MedicalBreakthrough #CzechExcellence #PersonalizedMedicine #HealthcareInnovation #CzechTradeScandinavia

To optimize the effectiveness of immunotherapy, researchers are constantly exploring innovative strategies that bridge basic and clinical research. Insights from patient samples can reveal crucial information, such as identifying key proteins like TGFβ that may be targeted for improved treatment responses. This collaborative approach between bench and bedside research not only enhances current therapies but also paves the way for the next generation of cancer immunotherapy. #ImmunotherapyInsights #InnovativeResearchApproaches #CancerTreatmentStrategies #PatientSampleAnalysis #NextGenImmunotherapy BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X. Read more about this post here: https://lnkd.in/dgSv6MAT

🔬 Tata Memorial Centre's ₹100 Tablet: A Game-Changer in Cancer Prevention Tata Memorial Centre's groundbreaking research unveils a potential cancer-fighting drug at an unprecedented price of ₹100 per tablet. Recent findings suggest that dying cancer cells release particles that could potentially turn healthy cells cancerous. This discovery, presented by Prof. Indraneel Mittra from TMC's Advanced Centre for Treatment, Research, and Education in Cancer (ACTREC), shines a light on the fight against cancer in India. Furthermore, a unique combination of natural ingredients, identified by TMC researchers, shows promise in reducing side effects in patients with multiple myeloma. These findings represent a significant step forward in cancer treatment innovation and underscore Tata Memorial Centre's commitment to accessible and effective healthcare solutions. In true essence, such groundbreaking research not only offers hope to cancer patients but also establishes Atma Nirbhar Bharat. 🌟 #CancerResearch #innovation #cancerawareness #MedicalInnovation #TataMemorialCentre #HealthcareInnovation 🚀

Project: Botton-Champalimaud Pancreatic Cancer Centre Construction company: Montaengil Drywall and acoustic system: DVM Certified installation of acoustic system: Pimenta brothers. Designed in collaboration with Sachin Agshikar & João Laranjo Arquitectos, the new Botton-Champalimaud Pancreatic Cancer Centre follows a translational methodology to improve the success rate of cancer treatment and, ultimately, the quality of life for those affected by pancreatic disease. To increase operational efficiency and shorten the time required to treat each patient, the vertical circulation of the interior layout unites surgical services, research and clinical trials under one roof, creating a seamless patient experience and enhancing medical professionals’ ability to accelerate the discovery and implementation of novel therapies in pancreatic cancer care. Pimenta Brothers - Acoustic Solutions DVM Building Solutions #bottonchampalimaud #acousticsolutions #pimentabrotherscertifiedinstaller #acousticdesing